BP-3R

BP-3R

Overview

BP-3R is a synthetic research peptide modeled after advanced incretin-related pathways being studied for their role in metabolic regulation.

In laboratory settings, BP-3R analogs are examined for their potential influence on glucose metabolism, receptor activation, and lipid processing under controlled conditions.

Current scientific investigation includes its interaction with multiple incretin receptor pathways, including GLP-1 and GIP, along with additional receptor activity being explored in next-generation tri-agonist research models.

Scientific Background

BP-3R is described in research contexts as a novel peptide sequence designed to mimic functional characteristics associated with multi-pathway incretin signaling.

In vitro studies often focus on receptor binding affinity, cyclic AMP (cAMP) signaling pathways, and extended peptide stability.

Its structure aligns with emerging tri-agonist research models, allowing for exploration of receptor interaction, signaling efficiency, and structure-function relationships relevant to metabolic pathway modeling in controlled laboratory environments.

Specifications

• Molecular Formula: C₂₂₄H₃₄₈N₅₆O₆₇
• Sequence: Synthetic analog — multi-receptor incretin agonist
• Purity: ≥99%
• Form: Lyophilized powder
• Storage: -20°C
• Solubility: Sterile water or bacteriostatic water

Disclaimer

For laboratory research use only. Not for human consumption, medical use, or veterinary use.

Bourbon Peptides — Research Grade Purity.

Search terms: reta, Reta, retatrutie, , glp3, GLP3, glp-3, GLP-3, triple agonist, tri agonist, incretin research, BP-3R, bp-3r